MDCO News and Press, The Medicines Company From 06/04/19

InsiderInsights' Daily Round-Up articles rate the "significance" of the top 10 dollar value insider purchases and sales filed at the SEC on the Title date. Dollar value is only the most basic metric to assess the significance of an insider transaction, however, and there are many more "Signi...

Market Pulse The month of May thus far has been mostly a downward ride with an occasional rise, proving to be a mere bunny bump, as indexes have eroded persistently on the lack of a trade resolution with China, an outcome that at one point was considered to be almost in the bag. This is rais...

Short interest is often seen as a poor indicator for future price performance because it can represent conflicting signals. One one hand, its backward-looking as the stocks with the weakest operating and financial results typically decline against the market attracting further speculative sell...

Analyses  of two clinical trials, the Phase 2 ORION-1 study and the Phase 1 ORION-7 study, showed a treatment effect of The Medicines Company's (NASDAQ: MDCO ) inclisiran in patients with homozygous familial hypercholesterolemia (HoFH). The data were presented at the European Atherosc...

Inclisiran administration led to consistent LDL-C reductions, with no dose adjustment required regardless of renal function, in a combined analysis of ORION-1 and ORION-7 studies Late-breaking abstract presentation of ORION-2 study showed that inclisiran significantly lowered LDL-C wit...

Insider buying decreased significantly last week, with insiders purchasing $158.64 million of stock compared to $385.5 million in the week prior. Selling, on the other hand, almost doubled, with insiders selling $2.03 billion of stock last week compared to $1.15 billion in the week prior. S...

InsiderInsights' Daily Round Up articles rate the "significance" of the top 10 dollar value insider purchases and sales filed at the SEC on the Title date. Dollar value is only the most basic metric to assess the significance of an insider transaction, however, and there are many more "Signifi...

Higher short interest is an odd indicator in the market. On one hand, it's a good indicator of sentiment as a high level generally suggests skepticism of the company's outlook, bringing bears to expect eventually lower share prices. It's also a poor indicator because significant levels of shor...

Biotech Pulse The Nasdaq Biotech ( IBB ) and the S&P Biotech ( XBI ) indexes have struggled since March as the broader healthcare sector ( XLV ) declined following growing momentum amongst the presidential candidates for a universal healthcare plan. This was at a time when the broader ma...

Someone’s sitting in the shade today because someone planted a tree a long time ago. - Warren Buffett Writing about antibiotic innovators is a quandary for me because I have to balance between the need for investment profits for investors vs. my social responsibility. It's an inte...